Partnering in Research Beyond Borders
As the Company’s ‘radar’ for the next big wave of innovation, our Research Beyond Borders team is tasked with exploring emerging science and technologies. We take an agnostic approach to therapeutic area and modality, which allows us to explore new and disruptive ideas and technologies across the entire research spectrum.
Accessing innovation
‘Beyond borders’ also extends to how the practice of science is executed. Collaboration with the external scientific community is key. We bring together the talents and capabilities of our scientists with the expertise of innovation partners around the world to effectively incubate the most creative scientific ideas and build a birthplace for innovation.
Our research and partnering focus
Our expanding portfolio has a wide, opportunistic horizon. We are particularly interested in advancing drug discovery in areas of high unmet medical need, or where existing therapies are limited in efficacy, acceptability or applicability.
Learn more about Research Beyond Borders
Our infographic shows how we’re going beyond borders in different ways to access new ideas and new science.
Our partnering interests
- Gene Therapy: AAV Gene Therapy projects with first-in-class potential. Tissue selective AAV capsid variants with translational potential to patients; novel technology for spatio-temporal control of cargo expression, increased cargo size. Human tissue/organ models for translational screening or characterization of AAVs.
- Regenerative Medicine: Drug-based modulation of pathways/targets involved in the stimulation of human endogenous cells for tissue regeneration to ultimately restore physiological function to a pre-disease state.
- Endometriosis: disease-modifying, non-hormonal and non-analgesic concepts.
Disease area focus
Therapeutic concepts for indications with high patient need including:
- Genetic and rare diseases
- Tissue regeneration for cartilage and muscle diseases
- Heart failure
- Neuroprotection
- Endometriosis.
Related Content
